[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-240772-105":3,"detail-sidebar-cat-1-en-105":81,"doc-detail-240772-en":126},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","covid-19-vaccine-delivery-partnership-situation-report-april-2022","COVID-19 Vaccine Delivery Partnership - Situation Report - April 2022","","COVID-19 Vaccine Delivery Partnership situation reporting covers April 2022, summarizing global progress and performance across Advance Market Commitment (AMC) participants and concerted-support countries. The report highlights over 11.7 billion doses administered globally, population coverage by primary series, and regional disparities in low-income settings. It details dose delivery and administration along the manufacturer-to-administration chain, country-level target status, and vaccination progress among high-risk groups including healthcare workers and older populations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/template/","Template",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/template/presentations/","Presentations",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/template/covid-19-vaccine-delivery-partnership-situation-report-april-2022/240772/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/covid-19-vaccine-delivery-partnership-situation-report-april-2022/240772.png","ImageObject",442,249,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-11",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the April 2022 situation report under the CoVDP?","Question",{"text":63,"@type":64},"The report summarizes COVID-19 vaccine delivery and vaccination progress across CoVDP/AMC participants during April 2022, including global coverage, dose administration, and progress toward coverage targets.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is progress measured across AMC participants and concerted-support countries?",{"text":68,"@type":64},"Progress is tracked using delivered doses and doses administered, including breakdowns along the manufacturer-to-administration chain, and status against national and WHO coverage targets as of mid-April 2022.",{"name":70,"@type":61,"acceptedAnswer":71},"What vaccination progress is reported for high-risk groups?",{"text":72,"@type":64},"The report focuses on healthcare workers and older populations, providing estimated shares that completed primary-series vaccination and noting regional differences in coverage and changes since late March 2022.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},240772,1791729710,{"code":4,"msg":82,"data":83},"success",[84,88,92,97,102,107,112,117,122],{"id":85,"doc_module":22,"doc_module_name":25,"category_name":29,"show_sort_weight":86,"slug":87},11,90,"presentations",{"id":55,"doc_module":22,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Resumes",80,"resumes",{"id":93,"doc_module":22,"doc_module_name":25,"category_name":94,"show_sort_weight":95,"slug":96},14,"Invoices",70,"invoices",{"id":98,"doc_module":22,"doc_module_name":25,"category_name":99,"show_sort_weight":100,"slug":101},15,"Posters",60,"posters",{"id":103,"doc_module":22,"doc_module_name":25,"category_name":104,"show_sort_weight":105,"slug":106},16,"Social Media",50,"social-media",{"id":108,"doc_module":22,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},17,"Forms",40,"forms",{"id":113,"doc_module":22,"doc_module_name":25,"category_name":114,"show_sort_weight":115,"slug":116},18,"Letters",30,"letters",{"id":118,"doc_module":22,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},21,"Paper Templates",5,"papers-templates",{"id":123,"doc_module":22,"doc_module_name":25,"category_name":124,"show_sort_weight":4,"slug":125},158,"General","general-158",{"code":4,"msg":82,"data":127},{"doc_id":79,"user_id":128,"nickname":42,"user_avatar":129,"doc_module":22,"category_id":85,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":108,"language":135,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":12,"update_tm":139,"read_time":140},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","COVID-19 Vaccine Delivery Partnership1  \nSituation Report: April 2022  \nThis report is produced by the COVID-19 Vaccine Delivery Partnership (CoVDP). It covers the month of April 2022.  \n GLOBAL SITUATION OVERVIEW2  \nFigure 1: Population coverage with a complete primary series across  \nAMC participants (92) as of 21 April 2022  \n􀁸 Global COVID-19 vaccination coverage progress  \nMore than 11.7 billion doses of COVID-19 vaccines have been administered globally (5% increase from 15 January 2022), and 126 of the 194 WHO member states have vaccinated more that 40% of their population and 54 countries have reached more than 70% of their population. Fifty-nine percent of the world population have been vaccinated with the primary series, however only 13% in low-income countries. The WHO Africa and Eastern Mediterranean regions account for the largest proportion of unvaccinated for the total population (81% and 49%, respectively, Figure 1) .  \n􀁸 AMC and CoVDP Countries for Concerted Support COVID-19 vaccination coverage progress  \nAmong the 4.9 billion COVID-19 vaccine doses delivered to the 90 vaccinating Advance Market Commitment (AMC) countries, a total of 3.8B doses have been administered as of 21 April 2022 (an  \n1 Recognizing the urgency of transforming vaccine doses into immunized communities, UNICEF, WHO, and Gavi launched the CoVDP in January 2022, an inter-agency initiative building on existing resources globally, regionally and in-country to accelerate COVID-19 vaccination in countries with the lowest coverage. The CoVDP primarily supports the 34 countries that were at or below 10% coverage in January 20221 and provides urgent, concerted support to a small, rotating list of countries. The CoVDP works with countries to understand bottlenecks to vaccination, and support them to access urgent operational funding, technical and surge assistance, political engagement and demand and supply planning required to plan, implement and scale their vaccination response and monitor progress towards targets. The COVID-19 Vaccine Delivery Partnership aligns around the principle of One Country Team led by government and partners, One Plan, One Budget and One Support Team.  \n2 Source data for global overview: COVID-19 Vaccine Delivery Partnership data  \nFigure 2: Current breakdown of vaccine doses along manufacturer-to  \nadministration chain across AMC participants (92) as of 21 April 2022  \nincrease of 3% from 31 March 2022, Figure 2) .3 Among the 34 countries for CoVDP concerted support with vaccination coverage at or below 10% as of 15 January 2022, 393M doses have been delivered, of which 199M have been administered, as of 12 May 2022 (up from 95.8M on 15 January 2022) . This represents a 108% increase in doses administered since 15 January 2022.  \n􀁸 Among the 81 vaccinating AMC countries that have a defined national coverage target and timeline, 7 (9%) are estimated to be on track to achieve their coverage target by the indicated timeline (down from  \n11 30 March 2022) . Three AMC countries have met their national coverage targets (up from two 30 March 2022) .  \n􀁸 Thirteen of the 90 vaccinating AMC countries4 have either met (4) or are estimated to be on track (9) to achieve the WHO 70% coverage target by 30 June 2022. The countries that have met the target are in the South East Asia and Western Pacific regions.  \nFigure 3: Status of progress against individual country coverage targets across  \nAMC participants (92) as of 21 April 2022  \n3 Two AMC countries are not vaccinating: 1) Eritrea, 2) DPR Korea  \n4 Gavi AMC list of countries  \n􀁸 Two of the 34 countries for concerted support are estimated to be on track to meet their national coverage target (Central African Republic and Chad), while none are on track to achieve the WHO 70% coverage target by June 2022 (Figure 3) .  \n􀁸 Among the 90 vaccinating AMC participants, coverage has increased from 28% to 45% since 15 January 2022, representing a 1.6 times increase across all low and middle","cbCaie0HfCYjWubF","https://ap.wps.com/l/cbCaie0HfCYjWubF","pdf",2703828,"English","# Global situation overview\n## Global COVID-19 vaccination coverage progress\n## AMC and CoVDP countries for concerted support\n# Vaccination progress among high-risk groups","[{\"question\":\"What is the purpose of the April 2022 situation report under the CoVDP?\",\"answer\":\"The report summarizes COVID-19 vaccine delivery and vaccination progress across CoVDP/AMC participants during April 2022, including global coverage, dose administration, and progress toward coverage targets.\"},{\"question\":\"How is progress measured across AMC participants and concerted-support countries?\",\"answer\":\"Progress is tracked using delivered doses and doses administered, including breakdowns along the manufacturer-to-administration chain, and status against national and WHO coverage targets as of mid-April 2022.\"},{\"question\":\"What vaccination progress is reported for high-risk groups?\",\"answer\":\"The report focuses on healthcare workers and older populations, providing estimated shares that completed primary-series vaccination and noting regional differences in coverage and changes since late March 2022.\"}]","COVID-19 Vaccine Delivery Partnership - Situation Report - April 2022 | PDF",1789165610,6]